Diabetes has been associated with more severe outcomes and higher mortality in coronavirus disease 2019 (COVID-19) patients compare to morbidity and mortality in patients without diabetes. Several mechanisms may play a role in this greater morbidity and mortality, especially uncontrolled hyperglycemia, an impaired immune system, pre-existing proinflammatory states, multiple comorbidities, and dysregulated angiotensin-converting enzyme 2 signaling. Thus, the diabetes medical community emergently needs to know about COVID-19 and its effects on patients with diabetes, as they must take precautions to carefully manage these patients during the COVID-19 pandemic. The Korean Diabetes Association provides some guidance and practical recommendations for the management of diabetes during the pandemic. This report provides insight into the association between diabetes and COVID-19, proper management of diabetes in patients with COVID-19 and an official suggestion by the Korean Diabetes Association for managing the COVID-19 outbreak.

Citations

Citations to this article as recorded by  

• Medical comorbidities as predictors of COVID-19 short-term mortality: A historical cohort study in Indonesia
  Rizaldy Taslim Pinzon, Vanessa Veronica
  Tzu Chi Medical Journal.2023; 35(1): 53.     CrossRef
• A year of experience with COVID‐19 in patients with cancer: A nationwide study
  Mina Khosravifar, Sogol Koolaji, Negar Rezaei, Ali Ghanbari, Seyedeh Melika Hashemi, Erfan Ghasemi, Ali Bitaraf, Ozra Tabatabaei‐Malazy, Nazila Rezaei, Sahar Mohammadi Fateh, Arezou Dilmaghani‐Marand, Rosa Haghshenas, Ameneh Kazemi, Erfan Pakatchian, Farz
  Cancer Reports.2023;[Epub]     CrossRef
• Impact of COPD on clinical and CT characteristics of COVID-19-associated pneumonia: single tertiary center experience
  Yevgeniya Filippenko, Marianna Zagurovskaya, Aigul Abdrakhmanova, Saule Kassenova, Zhanar Zhakenova, Aizat Aimakhanova, Zhamilya Zholdybay
  Egyptian Journal of Radiology and Nuclear Medicine.2022;[Epub]     CrossRef
• Being caught in the perfect storm of a diabetes epidemic and the COVID‐19 pandemic: What should we do for our patients?
  Yunjung Cho, Kun‐Ho Yoon
  Journal of Diabetes Investigation.2021; 12(3): 297.     CrossRef
• COVID-19 associated with diabetes and other noncommunicable diseases led to a global health crisis
  Mark Thomaz Ugliara Barone, Belinda Ngongo, Simone Bega Harnik, Lucas Xavier de Oliveira, Dániel Végh, Patrícia Vieira de Luca, Hermelinda Cordeiro Pedrosa, Franco Giraudo, Roque Cardona-Hernandez, Nayanjeet Chaudhury, Luiz Menna-Barreto
  Diabetes Research and Clinical Practice.2021; 171: 108587.     CrossRef
• Impact of COPD on COVID-19 prognosis: A nationwide population-based study in South Korea
  Sang Chul Lee, Kang Ju Son, Chang Hoon Han, Seon Cheol Park, Ji Ye Jung
  Scientific Reports.2021;[Epub]     CrossRef
• Effects of a DPP-4 Inhibitor and RAS Blockade on Clinical Outcomes of Patients with Diabetes and COVID-19
  Sang Youl Rhee, Jeongwoo Lee, Hyewon Nam, Dae-Sung Kyoung, Dong Wook Shin, Dae Jung Kim
  Diabetes & Metabolism Journal.2021; 45(2): 251.     CrossRef
• Towards Telemedicine Adoption in Korea: 10 Practical Recommendations for Physicians
  Hun-Sung Kim
  Journal of Korean Medical Science.2021;[Epub]     CrossRef
• Nutritional information access and dietary behavior among people with diabetes during Covid-19 pandemic
  Yovita Puri Subardjo, Gumintang Ratna Ramadhan, Dika Betaditya, Muflihatus Syarifah, Nurafifah Fauziana Abidin
  IOP Conference Series: Earth and Environmental Science.2021; 746(1): 012027.     CrossRef
• Dissection of non-pharmaceutical interventions implemented by Iran, South Korea, and Turkey in the fight against COVID-19 pandemic
  Mohammad Keykhaei, Sogol Koolaji, Esmaeil Mohammadi, Reyhaneh Kalantar, Sahar Saeedi Moghaddam, Arya Aminorroaya, Shaghayegh Zokaei, Sina Azadnajafabad, Negar Rezaei, Erfan Ghasemi, Nazila Rezaei, Rosa Haghshenas, Yosef Farzi, Sina Rashedi, Bagher Larijan
  Journal of Diabetes & Metabolic Disorders.2021; 20(2): 1919.     CrossRef
• 2021 Clinical Practice Guidelines for Diabetes Mellitus in Korea
  Seung-Hyun Ko
  The Journal of Korean Diabetes.2021; 22(4): 244.     CrossRef
• Clinical Characteristics and Mortality Predictors of COVID-19 Patients Hospitalized at Nationally-Designated Treatment Hospitals
  Seong-Su Moon, Kwan Lee, Jungi Park, Seongcheol Yun, Yun Sik Lee, Dong Seok Lee
  Journal of Korean Medical Science.2020;[Epub]     CrossRef
• Response: The Risk of Diabetes on Clinical Outcomes in Patients with Coronavirus Disease 2019: A Retrospective Cohort Study (Diabetes Metab J 2020;44:405–13)
  Seung Min Chung, June Hong Ahn, Jun Sung Moon
  Diabetes & Metabolism Journal.2020; 44(4): 625.     CrossRef
• Diabetes Mellitus and COVID-19
  Jeong Hyun Park
  The Journal of Korean Diabetes.2020; 21(3): 116.     CrossRef

Citations

Citations to this article as recorded by  

• The relationship of age, sex and prothrombin time related to the severity and mortality of COVID-19 patients with diabetes mellitus: a systematic review and meta analysis
  Audrey Fabianisa Mirza, Ceria Halim, Mutiara Indah Sari
  F1000Research.2024; 11: 729.     CrossRef
• The relationship of age, sex and prothrombin time related to the severity and mortality of COVID-19 patients with diabetes mellitus: a systematic review and meta analysis
  Audrey Fabianisa Mirza, Ceria Halim, Mutiara Indah Sari
  F1000Research.2024; 11: 729.     CrossRef
• The relationship of age, sex and prothrombin time related to the severity of COVID-19 patients with diabetes mellitus: a systematic review and meta analysis
  Audrey Fabianisa Mirza, Ceria Halim, Mutiara Indah Sari
  F1000Research.2024; 11: 729.     CrossRef
• The relationship of age, sex and prothrombin time related to the severity of COVID-19 patients with diabetes mellitus: a systematic review and meta analysis
  Audrey Fabianisa Mirza, Ceria Halim, Mutiara Indah Sari
  F1000Research.2024; 11: 729.     CrossRef
• The relationship of age, sex and prothrombin time related to the severity of COVID-19 patients with diabetes mellitus: a systematic review and meta analysis
  Audrey Fabianisa Mirza, Ceria Halim, Mutiara Indah Sari
  F1000Research.2024; 11: 729.     CrossRef
• Adult-Onset Type 1 Diabetes Development Following COVID-19 mRNA Vaccination
  Hyeyeon Moon, Sunghwan Suh, Mi Kyoung Park
  Journal of Korean Medical Science.2023;[Epub]     CrossRef
• Severity of Symptoms and Mortality in Diabetic Patients with COVID- 19 Infection. Review
  Zahraa ALBasry, Abeer Abdulhadi Rashid, Shaymaa Hasan Abbas
  Al Mustansiriyah Journal of Pharmaceutical Sciences.2023; 23(1): 91.     CrossRef
• Risk phenotypes of diabetes and association with COVID-19 severity and death: an update of a living systematic review and meta-analysis
  Sabrina Schlesinger, Alexander Lang, Nikoletta Christodoulou, Philipp Linnerz, Kalliopi Pafili, Oliver Kuss, Christian Herder, Manuela Neuenschwander, Janett Barbaresko, Michael Roden
  Diabetologia.2023; 66(8): 1395.     CrossRef
• COVID-19 and Cardiovascular Comorbidities
  Dirk Müller-Wieland, Nikolaus Marx, Michael Dreher, Katharina Fritzen, Oliver Schnell
  Experimental and Clinical Endocrinology & Diabetes.2022; 130(03): 178.     CrossRef
• Prevalence and impact of diabetes in hospitalized COVID‐19 patients: A systematic review and meta‐analysis
  Sian A. Bradley, Maciej Banach, Negman Alvarado, Ivica Smokovski, Sonu M. M. Bhaskar
  Journal of Diabetes.2022; 14(2): 144.     CrossRef
• Does metformin affect outcomes in COVID‐19 patients with new or pre‐existing diabetes mellitus? A systematic review and meta‐analysis
  Adithan Ganesh, Michael D. Randall
  British Journal of Clinical Pharmacology.2022; 88(6): 2642.     CrossRef
• Cardioprotective effect of extracellular vesicles derived from ticagrelor-pretreated cardiomyocyte on hyperglycemic cardiomyocytes through alleviation of oxidative and endoplasmic reticulum stress
  Ceylan Verda Bitirim, Zeynep Busra Ozer, Dunya Aydos, Kardelen Genc, Seyma Demirsoy, Kamil Can Akcali, Belma Turan
  Scientific Reports.2022;[Epub]     CrossRef
• Impact of diabetes on COVID‐19 mortality and hospital outcomes from a global perspective: An umbrella systematic review and meta‐analysis
  Stavroula Kastora, Manisha Patel, Ben Carter, Mirela Delibegovic, Phyo Kyaw Myint
  Endocrinology, Diabetes & Metabolism.2022;[Epub]     CrossRef
• Glycated Albumin and Glycated Albumin/HbA1c Predict the Progression of Coronavirus Disease 2019 from Mild to Severe Disease in Korean Patients with Type 2 Diabetes
  Jeongseon Yoo, Youngah Choi, Shin Ae Park, Ji Yeon Seo, Chul Woo Ahn, Jaehyun Han
  Journal of Clinical Medicine.2022; 11(9): 2327.     CrossRef
• Novel Glycemic Index Based on Continuous Glucose Monitoring to Predict Poor Clinical Outcomes in Critically Ill Patients: A Pilot Study
  Eun Yeong Ha, Seung Min Chung, Il Rae Park, Yin Young Lee, Eun Young Choi, Jun Sung Moon
  Frontiers in Endocrinology.2022;[Epub]     CrossRef
• Renin‐Angiotensin Aldosterone System Inhibitors and COVID‐19: A Systematic Review and Meta‐Analysis Revealing Critical Bias Across a Body of Observational Research
  Jordan Loader, Frances C. Taylor, Erik Lampa, Johan Sundström
  Journal of the American Heart Association.2022;[Epub]     CrossRef
• The relationship of age, sex and prothrombin time related to the severity and mortality of COVID-19 patients with diabetes mellitus: a systematic review and meta analysis
  Audrey Fabianisa Mirza, Ceria Halim, Mutiara Indah Sari
  F1000Research.2022; 11: 729.     CrossRef
• Evaluating the effect of COVID-19 on quality measures of patients with type 2 diabetes in two family nurse practitioner–owned clinics
  Wendy L. Wright, Patricia A. White, Meredith Welsh, Kelly Cutting
  Journal of the American Association of Nurse Practitioners.2022; 34(9): 1090.     CrossRef
• Early glycaemic variability increases 28-day mortality and prolongs intensive care unit stay in critically ill patients with pneumonia
  Seong Ho Kim, Ji Young Kim, Eun Song Kim, Il Rae Park, Eun Yeong Ha, Seung Min Chung, Jun Sung Moon, Ji Sung Yoon, Kyu Chang Won, Hyoung Woo Lee
  Annals of Medicine.2022; 54(1): 2724.     CrossRef
• Anti-inflammatory drugs and the renin-angiotensin-aldosterone system: Current knowledge and potential effects on early SARS-CoV-2 infection
  Iris Louise N. Cabbab, Rafael Vincent M. Manalo
  Virus Research.2021; 291: 198190.     CrossRef
• The Effect of Prior Angiotensin-Converting Enzyme Inhibitor and Angiotensin Receptor Blocker Treatment on Coronavirus Disease 2019 (COVID-19) Susceptibility and Outcome: A Systematic Review and Meta-analysis
  Jiuyang Xu, Yaqun Teng, Lianhan Shang, Xiaoying Gu, Guohui Fan, Yijun Chen, Ran Tian, Shuyang Zhang, Bin Cao
  Clinical Infectious Diseases.2021; 72(11): e901.     CrossRef
• Diabetes predicts severity of COVID‐19 infection in a retrospective cohort: A mediatory role of the inflammatory biomarker C‐reactive protein
  Huilin Koh, Angela Mei Chung Moh, Ester Yeoh, Yi Lin, Serena Kiat Mun Low, Say Tat Ooi, Seng Kiong Tan, Jaime Hui Xian Lin, Caroline Wei Shan Hoong
  Journal of Medical Virology.2021; 93(5): 3023.     CrossRef
• Susceptibility for Some Infectious Diseases in Patients With Diabetes: The Key Role of Glycemia
  Jesús Chávez-Reyes, Carlos E. Escárcega-González, Erika Chavira-Suárez, Angel León-Buitimea, Priscila Vázquez-León, José R. Morones-Ramírez, Carlos M. Villalón, Andrés Quintanar-Stephano, Bruno A. Marichal-Cancino
  Frontiers in Public Health.2021;[Epub]     CrossRef
• Diabetes is most important cause for mortality in COVID-19 hospitalized patients: Systematic review and meta-analysis
  Giovanni Corona, Alessandro Pizzocaro, Walter Vena, Giulia Rastrelli, Federico Semeraro, Andrea M Isidori, Rosario Pivonello, Andrea Salonia, Alessandra Sforza, Mario Maggi
  Reviews in Endocrine and Metabolic Disorders.2021; 22(2): 275.     CrossRef
• COVID-19 and diabetes: Analysis of the scientific production indexed in Scopus
  Ibraín Enrique Corrales-Reyes, Frank Hernández-García, Christian R. Mejia
  Diabetes & Metabolic Syndrome: Clinical Research & Reviews.2021; 15(3): 765.     CrossRef
• Impact of diabetes mellitus on in-hospital mortality in adult patients with COVID-19: a systematic review and meta-analysis
  Halla Kaminska, Lukasz Szarpak, Dariusz Kosior, Wojciech Wieczorek, Agnieszka Szarpak, Mahdi Al-Jeabory, Wladyslaw Gawel, Aleksandra Gasecka, Milosz J. Jaguszewski, Przemyslawa Jarosz-Chobot
  Acta Diabetologica.2021; 58(8): 1101.     CrossRef
• Risk phenotypes of diabetes and association with COVID-19 severity and death: a living systematic review and meta-analysis
  Sabrina Schlesinger, Manuela Neuenschwander, Alexander Lang, Kalliopi Pafili, Oliver Kuss, Christian Herder, Michael Roden
  Diabetologia.2021; 64(7): 1480.     CrossRef
• Evolution of a Cohort of COVID-19 Infection Suspects Followed-Up from Primary Health Care
  Valle Coronado-Vázquez, Maria del Valle Ramírez-Durán, Juan Gómez-Salgado, María Silvia Dorado-Rabaneda, Elena Benito-Alonso, Marina Holgado-Juan, Cristina Bronchalo-González
  Journal of Personalized Medicine.2021; 11(6): 459.     CrossRef
• Efficacy and safety of dulaglutide 3.0 and 4.5 mg in patients aged younger than 65 and 65 years or older: Post hoc analysis of the AWARD‐11 trial
  Juan P. Frias, Enzo Bonora, Luis Nevárez Ruiz, Stanley H. Hsia, Heike Jung, Sohini Raha, David A. Cox, M. Angelyn Bethel, Manige Konig
  Diabetes, Obesity and Metabolism.2021; 23(10): 2279.     CrossRef
• Renin‐Angiotensin Aldosterone System Inhibitors in Primary Prevention and COVID‐19
  Jordan Loader, Erik Lampa, Stefan Gustafsson, Thomas Cars, Johan Sundström
  Journal of the American Heart Association.2021;[Epub]     CrossRef
• Predictive value of HbA1c for in-hospital adverse prognosis in COVID-19: A systematic review and meta-analysis
  Zheng Zhu, Yaqian Mao, Gang Chen
  Primary Care Diabetes.2021; 15(6): 910.     CrossRef
• High Fibrosis-4 Index Is Related with Worse Clinical Outcome in Patients with Coronavirus Disease 2019 and Diabetes Mellitus: A Multicenter Observational Study
  Sung-Woo Kim, Jae-Han Jeon, Jun Sung Moon, Mi Kyung Kim
  Endocrinology and Metabolism.2021; 36(4): 800.     CrossRef
• COVID-19 Vaccination for Endocrine Patients: A Position Statement from the Korean Endocrine Society
  Cheol Ryong Ku, Kyong Yeun Jung, Chang Ho Ahn, Jun Sung Moon, Ju Hee Lee, Eun Heui Kim, Hyemi Kwon, Hee Kyung Kim, Sunghwan Suh, Sangmo Hong, Jeonghoon Ha, Eun Roh, Jin Hwa Kim, Mi-kyung Kim
  Endocrinology and Metabolism.2021; 36(4): 757.     CrossRef
• A Systematic Review and Meta-analysis of Diabetes Associated Mortality in Patients with COVID-19
  Puneeta Gupta, Meeta Gupta, Neena KAtoch, Ketan Garg, Bhawna Garg
  International Journal of Endocrinology and Metabolism.2021;[Epub]     CrossRef
• Diabetes, Drug Treatment, and Mortality in COVID-19: A Multinational Retrospective Cohort Study
  Jennifer E. Nyland, Nazia T. Raja-Khan, Kerstin Bettermann, Philippe A. Haouzi, Douglas L. Leslie, Jennifer L. Kraschnewski, Leslie J. Parent, Patricia Sue Grigson
  Diabetes.2021; 70(12): 2903.     CrossRef
• Impact of Diabetes on COVID-19 Mortality and Hospital Outcomes, a Global Perspective: An ONTOP Systematic Review and Meta-Analysis
  Stavroula Kastora, Manisha Patel, Ben Carter, Mirela Delibegovic, Phyo Kyaw Myint
  SSRN Electronic Journal .2021;[Epub]     CrossRef
• Response: Acute Hyperglycemic Crises with Coronavirus Disease-19: Case Reports (Diabetes Metab J 2020;44:349–53)
  Na-young Kim, Eunyeong Ha, Jun Sung Moon, Yong-Hoon Lee, Eun Young Choi
  Diabetes & Metabolism Journal.2020; 44(3): 484.     CrossRef
• Diabetes Mellitus is Associated with Severe Infection and Mortality in Patients with COVID-19: A Systematic Review and Meta-analysis
  Luxiang Shang, Mengjiao Shao, Qilong Guo, Jia Shi, Yang Zhao, Jiasuoer Xiaokereti, Baopeng Tang
  Archives of Medical Research.2020; 51(7): 700.     CrossRef
• Clinical Characteristics and Mortality Predictors of COVID-19 Patients Hospitalized at Nationally-Designated Treatment Hospitals
  Seong-Su Moon, Kwan Lee, Jungi Park, Seongcheol Yun, Yun Sik Lee, Dong Seok Lee
  Journal of Korean Medical Science.2020;[Epub]     CrossRef
• Mortality Rate and Predictors of Mortality in Hospitalized COVID-19 Patients with Diabetes
  Dilaram Acharya, Kwan Lee, Dong Seok Lee, Yun Sik Lee, Seong-Su Moon
  Healthcare.2020; 8(3): 338.     CrossRef
• Letter: The Risk of Diabetes on Clinical Outcomes in Patients with Coronavirus Disease 2019: A Retrospective Cohort Study (Diabetes Metab J 2020;44:405–13)
  So-Yeon Kim, Kyung-Soo Kim
  Diabetes & Metabolism Journal.2020; 44(4): 621.     CrossRef
• Response: The Risk of Diabetes on Clinical Outcomes in Patients with Coronavirus Disease 2019: A Retrospective Cohort Study (Diabetes Metab J 2020;44:405–13)
  Seung Min Chung, June Hong Ahn, Jun Sung Moon
  Diabetes & Metabolism Journal.2020; 44(4): 625.     CrossRef
• The Clinical Characteristics and Outcomes of Patients with Moderate-to-Severe Coronavirus Disease 2019 Infection and Diabetes in Daegu, South Korea
  Mi Kyung Kim, Jae-Han Jeon, Sung-Woo Kim, Jun Sung Moon, Nan Hee Cho, Eugene Han, Ji Hong You, Ji Yeon Lee, Miri Hyun, Jae Seok Park, Yong Shik Kwon, Yeon-Kyung Choi, Ki Tae Kwon, Shin Yup Lee, Eon Ju Jeon, Jin-Woo Kim, Hyo-Lim Hong, Hyun Hee Kwon, Chi Yo
  Diabetes & Metabolism Journal.2020; 44(4): 602.     CrossRef
• Fasting Plasma Glucose Level Independently Predicts the Mortality of Patients with Coronavirus Disease 2019 Infection: A Multicenter, Retrospective Cohort Study
  Min Cheol Chang, Jong-Moon Hwang, Jae-Han Jeon, Sang Gyu Kwak, Donghwi Park, Jun Sung Moon
  Endocrinology and Metabolism.2020; 35(3): 595.     CrossRef
• Diabetes Mellitus and COVID-19
  Jeong Hyun Park
  The Journal of Korean Diabetes.2020; 21(3): 116.     CrossRef
• Management of Diabetes in Coronavirus Disease 2019: Prognosis and Practical Issues
  Hye Soon Kim
  The Journal of Korean Diabetes.2020; 21(3): 120.     CrossRef
• Independent Impact of Diabetes on the Severity of Coronavirus Disease 2019 in 5,307 Patients in South Korea: A Nationwide Cohort Study
  Sun Joon Moon, Eun-Jung Rhee, Jin-Hyung Jung, Kyung-Do Han, Sung-Rae Kim, Won-Young Lee, Kun-Ho Yoon
  Diabetes & Metabolism Journal.2020; 44(5): 737.     CrossRef
• Adverse impact of renin–angiotensin system blockade on the clinical course in hospitalized patients with severe COVID-19: a retrospective cohort study
  Jeong-Hoon Lim, Jang-Hee Cho, Yena Jeon, Ji Hye Kim, Ga Young Lee, Soojee Jeon, Hee Won Noh, Yong-Hoon Lee, Jaehee Lee, Hyun-Ha Chang, Hee-Yeon Jung, Ji-Young Choi, Sun-Hee Park, Chan-Duck Kim, Yong-Lim Kim, Shin-Woo Kim
  Scientific Reports.2020;[Epub]     CrossRef
• Coronavirus Disease 2019 and Diabetes: The Epidemic and the Korean Diabetes Association Perspective
  Junghyun Noh, Hyun-Ha Chang, In-Kyung Jeong, Kun Ho Yoon
  Diabetes & Metabolism Journal.2020; 44(3): 372.     CrossRef
• Diabetes and COVID-19: Global and regional perspectives
  In-Kyung Jeong, Kun Ho Yoon, Moon Kyu Lee
  Diabetes Research and Clinical Practice.2020; 166: 108303.     CrossRef

Citations

Citations to this article as recorded by  

• An analysis of risk factors for spontaneously occurring type 2 diabetes mellitus in rhesus macaques (Macaca mulatta)
  John P. Capitanio, Laura A. Del Rosso, JoAnn Yee, Marie‐Josee Marie‐France Lemoy
  Journal of Medical Primatology.2024;[Epub]     CrossRef
• Virus-induced diabetes mellitus: revisiting infection etiology in light of SARS-CoV-2
  Sundararaj Stanleyraj Jeremiah, Abu Saleh Md Moin, Alexandra E. Butler
  Metabolism.2024; 156: 155917.     CrossRef
• Is Pollution the Primary Driver of Infectious Syndemics?
  Merrill Singer
  Pathogens.2024; 13(5): 370.     CrossRef
• Connecting the Dots: How Herpes Viruses Influence Type 2 Diabetes: Insights from Experimental Researches
  Ushna Zameer, Eisha Saqib, Muhammad Salman Munshi, Samia Rohail
  Clinical Medicine Insights: Endocrinology and Diabetes.2024;[Epub]     CrossRef
• Exploring pathological link between antimicrobial and amyloid peptides
  Yijing Tang, Yanxian Zhang, Dong Zhang, Yonglan Liu, Ruth Nussinov, Jie Zheng
  Chemical Society Reviews.2024; 53(17): 8713.     CrossRef
• Infections and immunity: associations with obesity and related metabolic disorders
  Amitabha Ray, Melissa J. L. Bonorden, Rajashree Pandit, Katai J. Nkhata, Anupam Bishayee
  Journal of Pathology and Translational Medicine.2023; 57(1): 28.     CrossRef
• The effects of cytomegalovirus on brain structure following sport-related concussion
  Jonathan Savitz, Bryna D Goeckner, Bart N Ford, T Kent Teague, Haixia Zheng, Jaroslaw Harezlak, Rebekah Mannix, L Tugan Muftuler, Benjamin L Brett, Michael A McCrea, Timothy B Meier
  Brain.2023; 146(10): 4262.     CrossRef
• Does COVID-19 Infection Increase the Risk of Diabetes? Current Evidence
  Rachel Wong, Emily Lam, Carolyn T. Bramante, Steven G. Johnson, Jane Reusch, Kenneth J. Wilkins, Hsin-Chieh Yeh
  Current Diabetes Reports.2023; 23(8): 207.     CrossRef
• Epidemiological changes in cytomegalovirus end-organ diseases in a developed country: A nationwide, general-population-based study
  Seul Gi Yoo, Kyung Do Han, Kyoung Hwa Lee, Joohee Lim, Yeonju La, Da Eun Kwon, Sang Hoon Han
  Journal of Microbiology, Immunology and Infection.2022; 55(5): 812.     CrossRef
• Human MicroRNAs Attenuate the Expression of Immediate Early Proteins and HCMV Replication during Lytic and Latent Infection in Connection with Enhancement of Phosphorylated RelA/p65 (Serine 536) That Binds to MIEP
  Yeon-Mi Hong, Seo Yeon Min, Dayeong Kim, Subin Kim, Daekwan Seo, Kyoung Hwa Lee, Sang Hoon Han
  International Journal of Molecular Sciences.2022; 23(5): 2769.     CrossRef
• Burden and disease pathogenesis of influenza and other respiratory viruses in diabetic patients
  Swapna Thomas, Allal Ouhtit, Hebah A. Al Khatib, Ali H. Eid, Shilu Mathew, Gheyath K. Nasrallah, Mohamed M. Emara, Muna A. Al Maslamani, Hadi M. Yassine
  Journal of Infection and Public Health.2022; 15(4): 412.     CrossRef
• Health impact of seven herpesviruses on (pre)diabetes incidence and HbA1c: results from the KORA cohort
  Tim Woelfle, Birgit Linkohr, Tim Waterboer, Barbara Thorand, Jochen Seissler, Marc Chadeau-Hyam, Annette Peters
  Diabetologia.2022; 65(8): 1328.     CrossRef
• Association of pyogenic spondylitis with congestive heart failure in Korea: a nationwide longitudinal cohort study
  Chong Jin Park, Seung Hun Sheen, Jeong Gyun Kim, Hakyung Kim, Yeo Song Kim, In-bo Han, Je Beom Hong, Chun Kee Chung, Seil Sohn
  Journal of Korean Society of Geriatric Neurosurgery.2022; 18(1): 8.     CrossRef
• The Role of CMV Infection in Primary Lesions, Development and Clinical Expression of Atherosclerosis
  Carmen Valentina Cristescu, Sophie Alain, Simona Maria Ruță
  Journal of Clinical Medicine.2022; 11(13): 3832.     CrossRef
• Type 2 diabetes and viral infection; cause and effect of disease
  Tamara Turk Wensveen, Dora Gašparini, Dario Rahelić, Felix M. Wensveen
  Diabetes Research and Clinical Practice.2021; 172: 108637.     CrossRef
• Cytomegalovirus Disease, Short-Term Cardiovascular Events and Graft Survival in a Cohort of Kidney Transplant Recipients With High CMV IgG Seroprevalence
  James S. Díaz, Fabián A. Jaimes
  Progress in Transplantation.2021; 31(2): 126.     CrossRef
• Prevalence of carbohydrate metabolism disorders in patients with new coronavirus infection
  T. N. Markova, M. A. Lysenko, A. A. Ivanova, E. S. Pavlova, A. A. Ponomareva, V. V. Chibisova, T. K. Isaev, D. O. Sinyavkin, A. M. Mkrtumyan
  Diabetes mellitus.2021; 24(3): 222.     CrossRef
• Immunological Mechanisms of Sickness Behavior in Viral Infection
  Mia Krapić, Inga Kavazović, Felix M. Wensveen
  Viruses.2021; 13(11): 2245.     CrossRef
• Association between cytomegalovirus end-organ diseases and moderate-to-severe dementia: a population-based cohort study
  Kyoung Hwa Lee, Da Eun Kwon, Kyung Do Han, Yeonju La, Sang Hoon Han
  BMC Neurology.2020;[Epub]     CrossRef

Citations

Citations to this article as recorded by  

• Effect of HCV eradication by DAAs on liver steatosis, carotid atherosclerosis, and associated metabolic comorbidities: A systematic review
  Annalisa Cespiati, Inês Coelho Rodrigues, Inês Santos, Sara Policarpo, Sofia Carvalhana, Anna Ludovica Fracanzani, Helena Cortez‐Pinto
  Liver International.2024; 44(5): 1075.     CrossRef
• The role of treatment of hepatitis C with direct‐acting antiviral agents on glycaemic control in diabetic patients: An updated systematic review and meta‐analysis
  Bing Chen, Umair Iqbal, Shivani K. Desai, Jacob Gries, Elijah Verheyen, Mengdan Xie, Maan El Halabi, Sara Gaines, Ilan Weisberg
  Journal of Viral Hepatitis.2024; 31(10): 633.     CrossRef
• Prediction of response to sofosbuvir-based therapy using serum interleukin-12 and single nucleotide polymorphism of the interleukin 28B gene as predictive factors in HCV positive genotype-4 patients
  Doaa Mohamed Abdelnajid, Ahmed Y. Elmowafy, Lionel Rostaing, Marwa T. Elrakaiby
  Medicine.2023; 102(28): e34125.     CrossRef
• Hypoglycemia associated with direct‐acting anti‐hepatitis C virus drugs: An epidemiologic surveillance study of the FDA adverse event reporting system (FAERS)
  Yu Zhou, Wenhuo Xie, Chenhua Zheng, Libin Liu, Zhou Chen, Xiaolu Wang
  Clinical Endocrinology.2022; 96(5): 690.     CrossRef
• Hepatitis C: Problems to extinction and residual hepatic and extrahepatic lesions after sustained virological response
  Sara Cuesta-Sancho, Mercedes Márquez-Coello, Francisco Illanes-Álvarez, Denisse Márquez-Ruiz, Ana Arizcorreta, Fátima Galán-Sánchez, Natalia Montiel, Manuel Rodriguez-Iglesias, José-Antonio Girón-González
  World Journal of Hepatology.2022; 14(1): 62.     CrossRef
• Therapy of Chronic Viral Hepatitis: The Light at the End of the Tunnel?
  Giorgio Maria Saracco, Alfredo Marzano, Mario Rizzetto
  Biomedicines.2022; 10(3): 534.     CrossRef
• Hépatite B et C: une mise à jour sur lʼhépatite virale chronique
  Marie Ongaro, Francesco Negro
  Schweizer Gastroenterologie.2022; 3(1): 19.     CrossRef
• Effect of achieving sustained virological response with direct-acting antiviral agents on glycemic control in diabetic patients with chronic hepatitis C infection
  Mohamed El-Kassas, Runia El-Folly, Maram Aboromia, Heba Aly, Mohamed Bahgat, Mostafa Hamed
  Egyptian Liver Journal.2022;[Epub]     CrossRef
• Hepatitis C virus infection and diabetes: A complex bidirectional relationship
  Stefano Ciardullo, Alessandro Mantovani, Antonio Ciaccio, Marco Carbone, Pietro Invernizzi, Gianluca Perseghin
  Diabetes Research and Clinical Practice.2022; 187: 109870.     CrossRef
• Does Hepatitis C Virus Treatment by Directly Acting Antivirals Obligate Shifting Patients with Type 2 Diabetes from Oral Hypoglycemic Drugs to Insulin Therapy?
  Rasha Youssef Hagag, Ahmed Fawzy Selim, Omneya Darrag, Hassan Zied, Mohamed Sabry Aboelnasr
  Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy.2022; Volume 15: 1261.     CrossRef
• Metabolic changes in chronic hepatitis C patients receiving direct acting antivirals
  Nehal K. Abdel Fattah, Sara M. Shaheen, Osama A. Ahmed, Kadry Elsaeed, Nagwa A. Sabri
  F1000Research.2022; 11: 649.     CrossRef
• Hepatitis C virus, insulin resistance, and diabetes: A review
  Nabeel Alzahrani
  Microbiology and Immunology.2022; 66(10): 453.     CrossRef
• The Extent of Insulin Resistance in Patients That Cleared Viral Hepatitis C Infection and the Role of Pre-Existent Type 2 Diabetes Mellitus: A Meta-Analysis
  Marian-Sorin Popescu, Andrei Ioan Drocas, Andrei Osman, Dan-Mihai Firu, Vlad Pădureanu, Cristina Maria Mărginean, Daniel-Cristian Pîrvu, Radu Mitruț, Dragoș Nicolae Mărgăritescu, Antonia Radu, Daniela Calina, Anca Oana Docea, Paul Mitruț
  Reports.2022; 5(4): 42.     CrossRef
• Global longitudinal strain as a predictor of short-term effect of oral antiviral regimens on myocardium in Egyptian patients with chronic viral hepatitis C
  Hazem Mohammad-Ali Farrag, Mina Samir Monir, Wael Soliman Abdel-Dayem, Hisham Abdel-Haleem Ali, Alaa Mohammad Ibrahim
  The Egyptian Heart Journal.2021;[Epub]     CrossRef
• Residual risk of liver disease after hepatitis C virus eradication
  Francesco Negro
  Journal of Hepatology.2021; 74(4): 952.     CrossRef
• Extrahepatic Manifestations of Chronic HCV Infection
  Dan L. Longo, Patrice Cacoub, David Saadoun
  New England Journal of Medicine.2021; 384(11): 1038.     CrossRef
• Metabolic Evaluation in Patients With Hepatitis C Treated With Direct Antiviral Agents
  Sergio Estefan, Carlos Eduardo Brandão-Melo, Cintia Marques dos Santos Silva, Danilo Cosme Klein Gomes, Paula Cardoso, Marcia Helena S. Costa
  Frontiers in Medicine.2021;[Epub]     CrossRef
• Current situation of viral hepatitis in Egypt
  Ashraf Elbahrawy, Marwa K. Ibrahim, Ahmed Eliwa, Mohamed Alboraie, Ali Madian, Hussein Hassan Aly
  Microbiology and Immunology.2021; 65(9): 352.     CrossRef
• The impact of direct-acting antiviral treatment on glycemic homeostasis in patients with chronic hepatitis C
  Marco SACCO, Giorgio M. SARACCO
  Minerva Gastroenterology.2021;[Epub]     CrossRef
• The impact of HCV eradication on hyperglycemia, insulin resistance, cytokine production, and insulin receptor substrate-1 and 2 expression in patients with HCV infection
  Basant Mahmoud, Adel Abdel Moneim, Doaa Mabrouk
  Clinical and Experimental Medicine.2021; 22(4): 583.     CrossRef
• Systematic review: chronic viral hepatitis and metabolic derangement
  Chia‐Chi Wang, Pin‐Nan Cheng, Jia‐Horng Kao
  Alimentary Pharmacology & Therapeutics.2020; 51(2): 216.     CrossRef
• Effect of treatment with direct antiviral agents (DAAs) on glycemic control in patients with type 2 diabetes mellitus & hepatitis C virus genotype 4
  Hassan Yousef Zied, Nashwa Mohamed Abo Alnasr, Amal Said El-Bendary, Sherief Abd-Elsalam, Rasha Youssef Hagag
  Diabetes & Metabolic Syndrome: Clinical Research & Reviews.2020; 14(4): 679.     CrossRef
• Impact of Treatment with Direct Acting Antiviral Drugs on Glycemic Control in Patients with Hepatitis C and Diabetes Mellitus
  Pradeep Kumar Mada, Matthew E. Malus, Arvin Parvathaneni, Bing Chen, Gabriel Castano, Sharon Adley, Maureen Moore, Michinari Hieda, Mohammed J. Alam, Mark Feldman, John William King
  International Journal of Hepatology.2020; 2020: 1.     CrossRef
• Cirrhosis and insulin resistance: current knowledge, pathophysiological mechanisms, complications and potential treatments
  Frédéric Clarembeau, Georgia Bale, Nicolas Lanthier
  Clinical Science.2020; 134(16): 2117.     CrossRef
• Treatment of Hepatitis C Virus and Long-Term Effect on Glycemic Control
  Jennifer Andres, Michael Barros, Michael Arutunian, Huaqing Zhao
  Journal of Managed Care & Specialty Pharmacy.2020; 26(6): 775.     CrossRef
• Natural History of Hepatic and Extrahepatic Hepatitis C Virus Diseases and Impact of Interferon-Free HCV Therapy
  Francesco Negro
  Cold Spring Harbor Perspectives in Medicine.2020; 10(4): a036921.     CrossRef
• The Effect of Viral Clearance Achieved by Direct-Acting Antiviral Agents on Hepatitis C Virus Positive Patients with Type 2 Diabetes Mellitus: A Word of Caution after the Initial Enthusiasm
  Davide Giuseppe Ribaldone, Marco Sacco, Giorgio Maria Saracco
  Journal of Clinical Medicine.2020; 9(2): 563.     CrossRef
• Metabolic and renal changes in patients with chronic hepatitis C infection after hepatitis C virus clearance by direct‐acting antivirals
  Riccardo Nevola, Luca Rinaldi, Letizia Zeni, Ferdinando C Sasso, Pia C Pafundi, Barbara Guerrera, Aldo Marrone, Mauro Giordano, Luigi E Adinolfi
  JGH Open.2020; 4(4): 713.     CrossRef
• Effect of eradication of HCV infection by direct-acting antivirals in diabetic HCV-infected patients as regards glycemic control
  Mohamed Mohei El Badry, Doaa Abdelhady Ali, Noha Hamdy Eltaweel, Marwa A. Abdel-Wahed
  Egyptian Liver Journal.2020;[Epub]     CrossRef
• Direct-acting antiviral agents decrease haemoglobin A1c level in patients with diabetes infected with hepatitis C virus: A systematic review & meta-analysis
  Kamolyut Lapumnuaypol, David Pisarcik, Prapaipan Putthapiban, Weera Sukhumthammarat, Karn Wijarnpreecha, Charat Thongprayoon, Patompong Ungprasert
  Indian Journal of Medical Research.2020; 152(6): 562.     CrossRef
• Fisiopatología de la hepatitis C y diabetes mellitus. Hacia la cura de dos epidemias en el siglo XXI
  Harold Ariel Muñoz Díaz, Adán José Lúquez Mindiola, Andrés José Gómez Aldana
  Revista Colombiana de Gastroenterología.2019; 34(3): 277.     CrossRef
• Treatment with direct-acting antivirals improves peripheral insulin sensitivity in non-diabetic, lean chronic hepatitis C patients
  Giacomo Gastaldi, Diana Gomes, Philippe Schneiter, Xavier Montet, Luc Tappy, Sophie Clément, Francesco Negro, Jee-Fu Huang
  PLOS ONE.2019; 14(6): e0217751.     CrossRef
• The impact of a successful treatment of hepatitis C virus on glyco-metabolic control in diabetic patients: a systematic review and meta-analysis
  Carla Carnovale, Marco Pozzi, Alice Dassano, Francesca D’Addio, Marta Gentili, Carlo Magni, Emilio Clementi, Sonia Radice, Paolo Fiorina
  Acta Diabetologica.2019; 56(3): 341.     CrossRef
• Sustained Improvement in Type 2 Diabetes Mellitus is Common After Treatment of Hepatitis C Virus With Direct-acting Antiviral Therapy
  Amir Gilad, Zachary P. Fricker, Adam Hsieh, Dylan D. Thomas, Toni Zahorian, David P. Nunes
  Journal of Clinical Gastroenterology.2019; 53(8): 616.     CrossRef
• Hepatitis C virus infection is associated with hepatic and adipose tissue insulin resistance that improves after viral cure
  Teegan R. Lim, Jonathan M. Hazlehurst, Andrei I. Oprescu, Matthew J. Armstrong, Sewa F. Abdullah, Nigel P. Davies, Robert Flintham, Peter Balfe, David J. Mutimer, Jane A. McKeating, Jeremy W. Tomlinson
  Clinical Endocrinology.2019; 90(3): 440.     CrossRef
• Direct‐acting antivirals for HCV treatment in older patients: A systematic review and meta‐analysis
  Rosanna Villani, Matteo Monami, Francesca Di Cosimo, Gilda Fioravanti, Edoardo Mannucci, Gianluigi Vendemiale, Gaetano Serviddio
  Journal of Viral Hepatitis.2019; 26(11): 1249.     CrossRef
• Chronic Hepatitis C Association with Diabetes Mellitus and Cardiovascular Risk in the Era of DAA Therapy
  Sylvia Drazilova, Jakub Gazda, Martin Janicko, Peter Jarcuska
  Canadian Journal of Gastroenterology and Hepatology.2018; 2018: 1.     CrossRef
• The comprehensive outcomes of hepatitis C virus infection: A multi‐faceted chronic disease
  Zobair Younossi, Georgios Papatheodoridis, Patrice Cacoub, Francesco Negro, Heiner Wedemeyer, Linda Henry, Angelos Hatzakis
  Journal of Viral Hepatitis.2018; 25(S3): 6.     CrossRef
• Poor Glycemic Control and Abrupt Onset of Diabetes in HCV Patients Receiving direct-acting Antiviral Drugs: Case Series
  Braira Wahid, Muhammad Wasim, Komal Saleem, Muhammad Waqar, Sajjad, Khansa Wahid, Manzoor Hussain, Muhammad Idrees
  Future Virology.2018; 13(8): 525.     CrossRef
• Risk of diabetes in HIV‐infected patients is associated with cirrhosis but not with chronic HCV coinfection in a French nationwide HIV cohort
  A. Provoost, M. Dramé, L. Cotte, L. Cuzin, R. Garraffo, D. Rey, F. Raffi, I. Poizot‐Martin, P. Pugliese, F. Bani‐Sadr
  Alimentary Pharmacology & Therapeutics.2018; 48(3): 281.     CrossRef
• The effect of sustained virological response by direct-acting antivirals on insulin resistance and diabetes mellitus in patients with chronic hepatitis C
  Luigi Elio Adinolfi, Luca Rinaldi, Aldo Marrone, Mauro Giordano
  Expert Review of Anti-infective Therapy.2018; 16(8): 595.     CrossRef
• Glucose Metabolism Changes in Patients with Chronic Hepatitis C Treated with Direct Acting Antivirals
  Sylvia Drazilova, Martin Janicko, Lubomir Skladany, Pavol Kristian, Marian Oltman, Maria Szantova, Dusan Krkoska, Eva Mazuchova, Lubica Piesecka, Veronika Vahalova, Marek Rac, Ivan Schreter, Ladislav Virag, Tomas Koller, Adriana Liptakova, Miriam Ondrasov
  Canadian Journal of Gastroenterology and Hepatology.2018; 2018: 1.     CrossRef
• INSULIN RESISTANCE REDUCTION AFTER SUSTAINED VIROLOGICAL RESPONSE WITH DIRECT ACTING ANTIVIRAL:NOT EVERY POPULATION IMPROVES
  Vanessa Gutierrez de ANDRADE, Fábio da Silva YAMASHIRO, Cássio Vieira OLIVEIRA, Alecsandro MOREIRA, Fernanda Cristina WINCKLER, Giovanni Faria SILVA
  Arquivos de Gastroenterologia.2018; 55(3): 274.     CrossRef
• Expert Opinion on Managing Chronic HCV Infection in Patients with Type 2 Diabetes Mellitus
  Luigi Elio Adinolf, Ira Jacobson, Mark Bondin, Patrice Cacoub
  Antiviral Therapy.2018; 23(1_suppl): 11.     CrossRef

The metabolic syndrome refers to a well defined group of risk factors, including central obesity and inflammation, for the development of diabetes and cardiovascular disease. Interestingly, many studies have recently led to the emergence of somewhat unexpected relationships between several infectious diseases and various aspects of the metabolic syndrome. Our understanding of the mechanisms underlying these interactions is also rapidly developing and some of these are summarized in this article. We will focus first on bacterial infection, and most notably the role of gut microbiota in regulaton of both obesity and inflammation. In particular, we focus on the role of inflammasomes and propose that understanding the role of Toll-like receptors and Nod-like receptors in the pathogenesis of inflammatory disorders with or without infection may provide novel targets for prevention and/or treatment of associated diseases. Secondly, chronic bacterial or viral infection and emerging links with metabolism will be reviewed. Finally, consideratons of biomarkers for metabolic syndrome, in particular lipocalin-2, and their link with infection will be discussed.

Citations

Citations to this article as recorded by  

• The immunology of sickness metabolism
  Felix M. Wensveen, Marko Šestan, Bojan Polić
  Cellular & Molecular Immunology.2024; 21(9): 1051.     CrossRef
• The Antimicrobial Activity of Origanum vulgare L. Correlated with the Gastrointestinal Perturbation in Patients with Metabolic Syndrome
  Timea Claudia Ghitea, Amina El-Kharoubi, Mariana Ganea, Erika Bimbo-Szuhai, Tiberiu Sebastian Nemeth, Gabriela Ciavoi, Monica Foghis, Luciana Dobjanschi, Annamaria Pallag, Otilia Micle
  Molecules.2021; 26(2): 283.     CrossRef
• COVID-19 severity in relation to sociodemographics and vitamin D use
  Darya Saeed Abdulateef, Heshu Sulaiman Rahman, Jamal Mahmood Salih, Sangar Mahmoud Osman, Trifa Abdalla Mahmood, Shirwan Hama Salih Omer, Rana Adnan Ahmed
  Open Medicine.2021; 16(1): 591.     CrossRef
• Iron Reshapes the Gut Microbiome and Host Metabolism
  Amy Botta, Nicole G. Barra, Nhat Hung Lam, Samantha Chow, Kostas Pantopoulos, Jonathan D. Schertzer, Gary Sweeney
  Journal of Lipid and Atherosclerosis.2021; 10(2): 160.     CrossRef
• Alteration in Cellular Signaling and Metabolic Reprogramming during Viral Infection
  Anil Pant, Lara Dsouza, Zhilong Yang, Benjamin Gewurz, Vinayaka R. Prasad
  mBio.2021;[Epub]     CrossRef
• Factors increasing the risk of mortality and morbidity due to coronavirus infection in patients with metabolic syndrome
  Altansuvd Enkhtur, Joon-Sup Yoon, Chang-Woo Lee
  Precision and Future Medicine.2020; 4(3): 83.     CrossRef
• Holo-lipocalin-2–derived siderophores increase mitochondrial ROS and impair oxidative phosphorylation in rat cardiomyocytes
  Erfei Song, Sofhia V. Ramos, Xiaojing Huang, Ying Liu, Amy Botta, Hye Kyoung Sung, Patrick C. Turnbull, Michael B. Wheeler, Thorsten Berger, Derek J. Wilson, Christopher G. R. Perry, Tak W. Mak, Gary Sweeney
  Proceedings of the National Academy of Sciences.2018; 115(7): 1576.     CrossRef
• Tuberculosis of the Breast: An Initial Presentation of the Metabolic Syndrome with Type 2 Diabetes Mellitus in a Young Nigerian Woman
  M. A. Adeiza, R. Yusuf, A. A. Liman, P. Abur, F. Bello, A. A. Abba
  Case Reports in Infectious Diseases.2016; 2016: 1.     CrossRef
• Systematic Review of the Relation Between Intestinal Microbiota and Toll-Like Receptors in the Metabolic Syndrome: What Do We Know So Far?
  José Pedro Portela-Cidade, Marta Borges-Canha, Adelino Ferreira Leite-Moreira, Pedro Pimentel-Nunes
  GE Portuguese Journal of Gastroenterology.2015; 22(6): 240.     CrossRef
• Impact of Cadmium Exposure on the Association between Lipopolysaccharide and Metabolic Syndrome
  Seung Han, Kyoung Ha, Ja Jeon, Hae Kim, Kwan Lee, Dae Kim
  International Journal of Environmental Research and Public Health.2015; 12(9): 11396.     CrossRef
• Regulation of Iron and Its Significance in Obesity and Complications
  Yee Kwan Chan, Hye Kyoung Sung, Gary Sweeney
  The Korean Journal of Obesity.2014; 23(4): 222.     CrossRef
• Direct effects of adipokines on the heart: focus on adiponectin
  Min Park, Gary Sweeney
  Heart Failure Reviews.2013; 18(5): 631.     CrossRef
• The Thioredoxin System as a Therapeutic Target in Human Health and Disease
  Dler Faieeq Darweesh Mahmood, Amna Abderrazak, Khadija El Hadri, Thomas Simmet, Mustapha Rouis
  Antioxidants & Redox Signaling.2013; 19(11): 1266.     CrossRef
• Immunoglobulin E and mast cell proteases are potential risk factors of impaired fasting glucose and impaired glucose tolerance in humans
  Zhen Wang, Hong Zhang, Xu-Hui Shen, Kui-Li Jin, Guo-fen Ye, Wei Qiu, Li Qian, Bo Li, Yong-Hong Zhang, Guo-Ping Shi
  Annals of Medicine.2013; 45(3): 220.     CrossRef
• Immunoglobulin E and Mast Cell Proteases Are Potential Risk Factors of Human Pre-Diabetes and Diabetes Mellitus
  Zhen Wang, Hong Zhang, Xu-Hui Shen, Kui-Li Jin, Guo-fen Ye, Li Qian, Bo Li, Yong-Hong Zhang, Guo-Ping Shi, Yiqing Song
  PLoS ONE.2011; 6(12): e28962.     CrossRef

Citations

Citations to this article as recorded by  

• Relationship of traditional and nontraditional cardiovascular risk factors to coronary artery calcium in type 2 diabetes
  Ju-Yeon Sim, Ju-Hee Kim, Yu-Bae Ahn, Ki-Ho Song, Je-Ho Han, Bong-Yun Cha, Sook-Kyung Lee, Sung-Dae Moon
  Korean Diabetes Journal.2009; 33(6): 466.     CrossRef
• Transdifferentiation of Enteroendocrine K-cells into Insulin-expressing Cells
  Esder Lee, Jun Mo Yu, Min Kyung Lee, Gyeong Ryul Ryu, Seung-Hyun Ko, Yu-Bae Ahn, Sung-Dae Moon, Ki-Ho Song
  Korean Diabetes Journal.2009; 33(6): 475.     CrossRef